HSBC/CALL/PFIZER INC/70/0.1/18.12.24 Stock

Warrant

DE000HG6S3A4

Market Closed - BOERSE MUENCHEN 03:36:33 2024-06-07 pm EDT
0.011 EUR 0.00% Intraday chart for HSBC/CALL/PFIZER INC/70/0.1/18.12.24

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 0.011 0.00%
24-06-06 0.011 0.00%
24-06-05 0.011 0.00%
24-06-04 0.011 0.00%
24-06-03 0.011 0.00%

Real-time BOERSE MUENCHEN

Last update June 07, 2024 at 03:36 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer HSBC
WKN HG6S3A
ISINDE000HG6S3A4
Date issued 2022-11-08
Strike 70 $
Maturity 2024-12-18 (193 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.33
Lowest since issue 0.011
Delta0.02x
Omega 7.882
Premium144.65x
Gearing441.9x
Moneyness 0.4091
Difference Strike 41.42 $
Difference Strike %+59.17%
Spread 0.01
Spread %90.91%
Theoretical value 0.006000
Implied Volatility 53.61 %
Total Loss Probability 99.35 %
Intrinsic value 0.000000
Present value 0.006000
Break even 70.06 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.58 USD
Average target price
31.92 USD
Spread / Average Target
+11.67%
Consensus